Literature DB >> 865731

Effects of magnesium sulfate on toxemic patients in labor.

B K Young, H M Weinstein.   

Abstract

One hundred forty-four toxemic patients were studied by continuous electronic maternal and fetal monitoring. Ninety-seven were treated by intravenous bolus of 2 g MgSO4 every 1-2 hours, and 47 by intravenous drip MgSO4 at a rate of 1 g/hour. Clinical doses of MgSO4 do not affect maternal ECG, temperature, uterine contractions, or fetal heart rate. Intravenous bolus administration is frequently associated with slowing of maternal respirations and hypotension and occasionally with transient apnea.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 865731

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Does parenteral magnesium sulfate have an antiemetic effect during chemotherapy with cis-platinum?

Authors:  P E Ballmer; W H Reinhart
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Hypertension in pregnancy. Pathophysiology and management.

Authors:  W F Lubbe
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

3.  Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis.

Authors:  Emily Shepherd; Rehana A Salam; Deepak Manhas; Anne Synnes; Philippa Middleton; Maria Makrides; Caroline A Crowther
Journal:  PLoS Med       Date:  2019-12-06       Impact factor: 11.069

Review 4.  Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.

Authors:  Emily S Bain; Philippa F Middleton; Caroline A Crowther
Journal:  BMC Pregnancy Childbirth       Date:  2013-10-21       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.